(Q37946268)

25 August 2017

1 reference

title

A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients (English)

1 reference

25 August 2017

0 references

Staphylococcus aureus

1 reference

1 reference

Piraino B

1

1 reference

PubMed ID

2200261

25 August 2017

language of work or name

1 reference

1 August 1990

1 reference

American Journal of Kidney Diseases

25 August 2017

1 reference

25 August 2017

16

1 reference

25 August 2017

89-95

1 reference

25 August 2017

2

1 reference

The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

A five-year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Analysis of continuous ambulatory peritoneal dialysis-related Pseudomonas aeruginosa infections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Staphylococcal peritonitis in patients on continuous peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Colonization of skin and development of peritonitis due to coagulase-negative staphylococci in patients undergoing peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Effect of Rifampin on Nasal Carriage of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Effect of rifampin on nasal carriers of coagulase-positive staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis--a prospective, randomized comparison of intermittent v continuous therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Once weekly intraperitoneal therapy for gram-positive peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Vancomycin and netilmicin as first line treatment of peritonitis in CAPD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

Ultrasound as a tool in the diagnosis and management of exit-site infections in patients undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980560-9

7 January 2021

10.1016/S0272-6386(12)80560-9

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

2200261